RESEARCH &
DEVELOPMENT
Research & Development Overview
ACI HealthCare Limited’s Research and Development function is focused on the scientific design and development of high-quality generic pharmaceutical products for regulated and emerging markets. Our R&D strategy is built on a structured, science-based approach that ensures products are developed with a clear understanding of quality, performance, and regulatory expectations from the earliest stages.
Development activities are guided by Quality-by-Design (QbD) principles, integrating formulation science, process understanding, and risk-based evaluation to achieve robust and reproducible outcomes. From feasibility and formulation development to scale-up and technology transfer, each stage is managed within a controlled framework that emphasizes consistency, efficiency, and lifecycle quality.
Our R&D organization is structured across formulation development, analytical development, and supporting quality functions, ensuring that products are developed with strong scientific justification and validated analytical methods. Stability studies, method validation, and regulatory documentation are conducted in alignment with international guidelines, supporting successful submissions in regulated markets.
Our Capabilities
ACI HealthCare Limited specializes in the development and manufacturing of oral solid dosage (OSD) pharmaceutical products, supported by advanced processing technologies, formulation expertise, and compliant manufacturing systems. Our capabilities are designed to address a wide spectrum of product requirements, from conventional dosage forms to more complex and differentiated generic formulations.
Manufacturing
Strengths
Our manufacturing platform integrates modern processing technologies and controlled production environments to ensure consistent quality, scalability, and operational efficiency.
Formulation &
Technology Platforms
Our formulation development capabilities support a diverse range of delivery systems designed to optimize drug release, stability, and patient compliance.
Technology Transfer & Global Generic Integration
Contract Manufacturing Capacity
ACI HealthCare Limited offers contract manufacturing solutions for pharmaceutical partners seeking a reliable, compliant, and scalable production platform. Our capabilities support the manufacturing of oral solid dosage products aligned with global regulatory expectations, enabling efficient execution of both development-stage and commercial supply programs.
We operate through a structured and collaborative model, ensuring that partner requirements, product specifications, and regulatory commitments are fully integrated into manufacturing processes. With systems aligned to cGMP, ICH guidelines, and data integrity standards, we ensure consistent product quality, traceability, and audit readiness across all operations.
Our approach emphasizes flexibility, transparency, and lifecycle support, from technology transfer and validation to routine commercial manufacturing and supply continuity. Through disciplined execution and a strong quality culture, ACI HealthCare serves as a trusted partner for dossier-driven manufacturing and long-term contract manufacturing engagements across global markets.
Why Partner with AHL
Regulatory Alignment
Built on globally accepted frameworks, ensuring compliance with US, EU, and international regulatory expectations
Integrated Capabilities
Seamless coordination across development, manufacturing, quality, and regulatory functions for efficient execution
Data Integrity & Transparency
Digitally enabled systems ensuring traceability, audit readiness, and trusted data throughout the product lifecycle
Scalable Manufacturing
Flexible, high-capacity production platform supporting consistent supply and multi-market demand
Scientific & Technical Expertise
Strong formulation and process understanding enabling robust, reproducible generic products
Reliable Partnership Model
Commitment to long-term collaboration through disciplined execution, responsiveness, and shared success